Allergan (AGN)
Undervalued Growth and Dividend Growth in Health Technology: Part 11
2019-03-19
Introduction Although many Health Technology Sector companies have significantly outperformed the market on a long-term basis, they have significantly underperformed the market since the beginning of 2015. With only a few minor exceptions, this is true for most companies, especially the pharmaceutical companies, operating in this sector. On the other hand, there are several examples […]